← Back
Data updated: Mar 10, 2026
NUVO PHARMS INC
ImmunologyGastroenterology
NUVO PHARMS INC is a generic drug manufacturer focused on Immunology, Gastroenterology.
1998
Since
11
Drugs
-
Trials
28
Approved (2yr)
Recent Activity
HYDROXYZINE HYDROCHLORIDE 2025-12-16
SULFASALAZINE 2025-11-04
NAPROXEN 2025-10-03
NAPROXEN 2025-08-28
Labeling
FOLIC ACID 2025-08-13
Labeling
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE 2025-08-04
Labeling
NAPROXEN 2025-06-13
Labeling
NAPROXEN 2025-06-13
Labeling
NAPROXEN 2025-06-13
Labeling
NAPROXEN 2025-06-13
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 50%
1 drugs
Gastroenterology 50%
1 drugs
Pipeline Strength Pro
Loading...
Active (5)
Discontinued (6)
Company Info
- First Approval
- 1998-12-24
- Latest
- 2023-03-08
- Applications
- 12
FDA Sponsor Names
NUVO PHARMS INCNUVO PHARMS